Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9OL6

Rabbit Ryanodine Receptor 1: DMSO Control Closed Conformation

This is a non-PDB format compatible entry.
Summary for 9OL6
Entry DOI10.2210/pdb9ol6/pdb
EMDB information70591
DescriptorRyanodine receptor 1, Peptidyl-prolyl cis-trans isomerase FKBP1B, CALCIUM ION, ... (4 entities in total)
Functional Keywordsion channel, calcium channel, transport protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains8
Total formula weight2312339.48
Authors
Molinarolo, S.M.,Van Petegem, F. (deposition date: 2025-05-12, release date: 2025-12-03)
Primary citationMolinarolo, S.,Valdivia, C.R.,Valdivia, H.H.,Van Petegem, F.
Cryo-electron microscopy reveals sequential binding and activation of Ryanodine Receptors by statin triplets.
Nat Commun, 2025
Cited by
PubMed Abstract: Statins are the most prescribed class of drugs and inhibit a key enzyme in the cholesterol biosynthesis pathway. Many patients have reported mild to severe muscle related symptoms and a subset are at risk for rhabdomyolysis. Sequence variants in RyR1, the skeletal muscle Ryanodine Receptor, correlate with intolerance to statins, but whether RyR1 can bind statins directly has remained unclear. Here we report cryo-EM structures of RyR1 in the absence and presence of atorvastatin, firmly establishing RyR1 as an unintended off-target. Our results show an unusual binding mode whereby three atorvastatin molecules bind together in a cleft formed by the pseudo-voltage sensing domain, making extensive interactions with each other and with RyR1. Atorvastatin activates RyR1 in a sequential way, whereby one statin per subunit can bind to the transmembrane region of a closed RyR1, with small structural perturbations that prime the channel for opening. Binding of two additional statins per subunit is associated with a widening of the pseudo-voltage sensing domain that triggers opening of the pore. Comparison with atorvastatin binding to HMG-CoA reductase, its intended target, offers clues on how to modify the statin to reduce RyR1 binding, while leaving binding to HMG-CoA reductase unperturbed.
PubMed: 41266329
DOI: 10.1038/s41467-025-66522-0
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.11 Å)
Structure validation

246031

数据于2025-12-10公开中

PDB statisticsPDBj update infoContact PDBjnumon